SGCB and multiminicore myopathy: Polymorphisms in eNOS primarily affect its expression and activity, while mutations in GUCY1A3 impair NO-sensitive soluble guanylyl cyclase function (sGC, the major receptor for NO), both contributing to the pathogenesis in MMD [12,49,50].